Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.
暂无分享,去创建一个
[1] T. Jones,et al. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. , 2005, Cutis.
[2] A. Kanwar,et al. A Comparative Study of 20% Azelaic Acid Cream Monotherapy versus a Sequential Therapy in the Treatment of Melasma in Dark-Skinned Patients , 2002, Dermatology.
[3] K. Kraemer,et al. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. , 1997, Journal of the American Academy of Dermatology.
[4] M. Metwalli,et al. Topical liquiritin improves melasma , 2000, International journal of dermatology.
[5] J. Q. Rosso,et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial , 2011 .
[6] R. Boissy,et al. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency , 2005, Experimental dermatology.
[7] G. Piérard,et al. Assessment of Topical Hypopigmenting Agents on Solar Lentigines of Asian Women , 2002, Dermatology.
[8] Wen‐yuan Zhu,et al. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. , 2008, The journal of investigative dermatology. Symposium proceedings.
[9] J. Camarasa,et al. Allergic contact dermatitis from kojic acid , 1998, Contact dermatitis.
[10] K. Kawai,et al. Contact allergy to kojic acid in skin care products , 1995, Contact dermatitis.
[11] R. Kundu,et al. Cosmetic Dermatology for Skin of Color , 2009 .
[12] A. Dupuy,et al. [Presenting skin disorders in black Afro-Caribbean patients: a multicentre study conducted in the Paris region]. , 2008, Annales de dermatologie et de venereologie.
[13] Jean-Paul Ortonne,et al. Melanin pigmentary disorders: treatment update. , 2005, Dermatologic clinics.
[14] R. Halder,et al. Management of dyschromias in ethnic skin , 2004, Dermatologic therapy.
[15] R Ruiz-Maldonado,et al. Postinflammatory hypopigmentation and hyperpigmentation. , 1997, Seminars in cutaneous medicine and surgery.
[16] J. Grichnik,et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. , 2003, Journal of the American Academy of Dermatology.
[17] Child,et al. A study of the spectrum of skin disease occurring in a black population in south‐east London , 1999, The British journal of dermatology.
[18] M. Chung,et al. Aloesin inhibits hyperpigmentation induced by UV radiation , 2002, Clinical and experimental dermatology.
[19] Il-Hwan Kim,et al. Whitening Effect of Salicylic Acid Peels in Asian Patients , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[20] P. Grimes,et al. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. , 2006, Cutis.
[21] A. Nanda,et al. A Prospective Survey of Pediatric Dermatology Clinic Patients in Kuwait: An Analysis of 10,000 Cases , 1999, Pediatric dermatology.
[22] P. Dunwell,et al. Study of the skin disease spectrum occurring in an Afro‐Caribbean population , 2003, International journal of dermatology.
[23] F. Cook-Bolden,et al. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. , 2008, Cutis.
[24] C. Goh,et al. PATTERN OF SKIN DISEASES AT THE NATIONAL SKIN CENTRE (SINGAPORE) FROM 1989–1990 , 1992, International journal of dermatology.
[25] R. Halder,et al. Topical agents used in the management of hyperpigmentation. , 2004, Skin therapy letter.
[26] B. Moncada,et al. A double‐blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma , 2004, International journal of dermatology.
[27] K. Graupe,et al. The Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream , 1991, International journal of dermatology.
[28] Z. Draelos. The combination of 2% 4‐hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups , 2006, Journal of cosmetic dermatology.
[29] C. Grover,et al. Efficacy of Hydroquinone (2%) Versus Tretinoin (0.025%) as Adjunct Topical Agents for Chemical Peeling in Patients of Melasma , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[30] M. Seiji,et al. Pigmentary incontinence in fixed drug eruptions. Histologic and electron microscopic findings. , 1983, Journal of the American Academy of Dermatology.
[31] J H Epstein,et al. Postinflammatory hyperpigmentation. , 1989, Clinics in dermatology.
[32] P. Grimes,et al. Incidence of common dermatoses in a predominantly black dermatologic practice. , 1983, Cutis.
[33] K. Jimbow,et al. Topical therapies for melasma and disorders of hyperpigmentation , 2001 .
[34] A. M. Alexander,et al. Pseudofolliculitis barbae in the military. A medical, administrative and social problem. , 1974, Journal of the National Medical Association.
[35] M. Jarratt. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. , 2004, Cutis.
[36] Frcpi,et al. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. , 1999 .
[37] Miguel R Sanchez,et al. Cutaneous diseases in Latinos. , 2003, Dermatologic clinics.
[38] Susan C. Taylor,et al. Common dermatologic disorders in skin of color: a comparative practice survey. , 2007, Cutis.
[39] W. Jacyk,et al. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. , 2001, Cutis.
[40] D. Aires,et al. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient. , 2009, Journal of drugs in dermatology : JDD.
[41] Hossein Hosseinzadeh,et al. Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds , 2008, Phytotherapy research : PTR.
[42] S. Hartshorne. Dermatological disorders in Johannesburg, South Africa , 2003, Clinical and experimental dermatology.
[43] A. Lim. Aesthetics and Cosmetic Surgery for Darker Skin Types , 2008 .
[44] Patricia K Farris,et al. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[45] H. Tagami,et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. , 1992, Pigment cell research.
[46] G. Kontochristopoulos,et al. Superficial chemical peels , 2006, Journal of cosmetic dermatology.
[47] J. Kim,et al. Treatment of post‐inflammatory hyperpigmentation using 1064‐nm Q‐switched Nd:YAG laser with low fluence: report of three cases , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[48] D. Bucks,et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. , 1996, Journal of the American Academy of Dermatology.
[49] J. Ortonne. Retinoic acid and pigment cells: a review of in‐vitro and in‐vivo studies , 1992, The British journal of dermatology.
[50] V. Verallo-Rowell,et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. , 1989, Acta dermato-venereologica. Supplementum.
[51] W. Roberts,et al. Chemical peeling in ethnic/dark skin , 2004, Dermatologic therapy.
[52] K. Hassun,et al. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma , 2007, Journal of cosmetic dermatology.
[53] Q. Nguyen,et al. AZELAIC ACID: PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND ITS THERAPEUTIC ROLE IN HYPERPIGMENTARY DISORDERS AND ACNE , 1995, International journal of dermatology.
[54] T. Alster,et al. Laser Surgery in Dark Skin , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[55] L. Hobbs,et al. Laser therapy on darker ethnic skin. , 2003, Dermatologic clinics.
[56] R. Halder,et al. Acne in ethnic skin. , 2003, Dermatologic clinics.
[57] P. Grimes. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[58] Susan C. Taylor,et al. Acne vulgaris in skin of color. , 2002, Journal of the American Academy of Dermatology.
[59] J. Lim. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[60] P. Beattie,et al. Cosmetic camouflage advice improves quality of life , 2002, The British journal of dermatology.
[61] D. Bissett,et al. Reduction in the appearance of facial hyperpigmentation by topical N‐acetyl glucosamine , 2007, Journal of cosmetic dermatology.
[62] D. Golde,et al. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. , 2002, Biochemistry.
[63] S. Itoh,et al. Protective Effect of Magnesium‐L‐Ascorbyl‐2 Phosphate Against Skin Damage Induced by UVB Irradiation , 1996, Photochemistry and photobiology.
[64] Monica Downie. CAMOUFLAGE THERAPY , 1984, The Australasian journal of dermatology.
[65] T. Shin,et al. Effects of α- and β-Arbutin on Activity of Tyrosinases from Mushroom and Mouse Melanoma , 1995 .
[66] J. Lear,et al. Postinflammatory hyperpigmentation in an Asian patient: a dramatic response to oral isotretinoin (13‐cis‐retinoic acid) , 2005, The British journal of dermatology.
[67] G. Hillebrand,et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer , 2002, The British journal of dermatology.
[68] P. Grimes. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. , 2004, Cutis.
[69] N. Raza,et al. Comparison of 30% salicylic acid with Jessner's solution for superficial chemical peeling in epidermal melasma. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[70] A. Beélik. Kojic acid , 1956, Advances in carbohydrate chemistry.
[71] S. Shuster,et al. Dermatological disorders. , 1972, Clinics in haematology.
[72] Z. Draelos. Skin lightening preparations and the hydroquinone controversy , 2007, Dermatologic therapy.
[73] Hall Hi,et al. Sun protection behaviors among African Americans. , 1999 .
[74] M. Cogswell,et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.
[75] E. Sharlow,et al. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. , 2001, The Journal of investigative dermatology.
[76] G. Norman,et al. Sun-protection behaviors among African Americans. , 2010, American journal of preventive medicine.
[77] L. Packer,et al. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. , 1994, The Journal of investigative dermatology.
[78] Y. Kubota,et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. , 1998, Pigment cell research.
[79] G. Kent. Testing a Model of Disfigurement: Effects of a Skin Camouflage Service on Well-being and Appearance Anxiety , 2002 .
[80] A. P. Kelly,et al. Community-based trial of a triple-combination agent for the treatment of facial melasma. , 2006, Cutis.
[81] Susan C. Taylor,et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. , 2002, Journal of the American Academy of Dermatology.
[82] P. Grimes. Management of hyperpigmentation in darker racial ethnic groups. , 2009, Seminars in cutaneous medicine and surgery.
[83] A. Hammad,et al. A survey of skin disease and skin-related issues in Arab Americans. , 2007, Journal of the American Academy of Dermatology.
[84] M. Fukuda,et al. Arbutin: mechanism of its depigmenting action in human melanocyte culture. , 1996, The Journal of pharmacology and experimental therapeutics.
[85] J. Fulton,et al. The Combination of Glycolic Acid and Hydroquinone or Kojic Acid for the Treatment of Melasma and Related Conditions , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[86] P. Grimes,et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. , 1998, Clinical therapeutics.
[87] R. F. Morgan,et al. Pseudofolliculitis barbae with keloids. , 1986, The Journal of emergency medicine.
[88] S. Nacht,et al. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. , 1996, Journal of microencapsulation.
[89] V. Callender. Acne in ethnic skin: special considerations for therapy , 2004, Dermatologic therapy.
[90] R. Schwartz,et al. Postinflammatory hyperpigmentation: a common but troubling condition , 2004, International journal of dermatology.
[91] Hyung Ok Kim,et al. Damage and Recovery of Skin Barrier Function After Glycolic Acid Chemical Peeling and Crystal Microdermabrasion , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[92] C. Berge,et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin 1 , 2004, International journal of cosmetic science.
[93] M. Tanioka,et al. Camouflage for vitiligo , 2009, Dermatologic therapy.
[94] W. Bollag,et al. Retinoids , 2010, Methods in Molecular Biology.
[95] H. Wulf,et al. Does chronic sunscreen use reduce vitamin D production to insufficient levels? , 2009, The British journal of dermatology.
[96] N. Kerrouche,et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma , 2008, The British journal of dermatology.
[97] M. Lawry,et al. Glycolic Acid Peels for Postinflammatory Hyperpigmentation in Black Patients: A Comparative Study , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[98] Z. Draelos,et al. Insight into skin lightening cosmeceuticals for women of color. , 2007, Journal of drugs in dermatology : JDD.
[99] A. Petit,et al. Motifs de consultation en dermatologie des sujets de peau noire d’origine africaine et antillaise : enquête multicentrique en région parisienne , 2008 .
[100] R. Halder,et al. Dermatology and Dermatological Therapy of Pigmented Skins , 2005 .
[101] P. Friedman,et al. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[102] A. Pandya,et al. Disorders of hyperpigmentation. , 2000, Dermatologic clinics.
[103] Dong-Seok Kim,et al. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo , 2010, International journal of dermatology.
[104] M. d’Ischia,et al. Mechanism of inhibition of melanogenesis by hydroquinone. , 1991, Biochimica et biophysica acta.
[105] A. Fleischer,et al. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. , 2000, Journal of the American Academy of Dermatology.
[106] J. Saurat,et al. Topical Methimazole as a New Treatment for Postinflammatory Hyperpigmentation: Report of the First Case , 2005, Dermatology.
[107] Z. Abdel‐Malek,et al. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. , 1988, Progress in clinical and biological research.
[108] Xiao-ru Wang,et al. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. , 2005, Journal of agricultural and food chemistry.
[109] T. Shin,et al. Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. , 1995, Bioscience, biotechnology, and biochemistry.
[110] J. Levitt. The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register. , 2007, Journal of the American Academy of Dermatology.
[111] A. Tirado-Sánchez,et al. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma , 2009, International journal of dermatology.
[112] A. Katsambas. RALGA (Diacnéal®), a Retinaldehyde and Glycolic Acid Association and Postinflammatory Hyperpigmentation in Acne – A Review , 2005, Dermatology.
[113] M. Makris,et al. A randomized, double‐blind, vehicle‐controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines , 2009, Clinical and experimental dermatology.
[114] J. Leyden,et al. Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study. , 2007, Journal of drugs in dermatology : JDD.